Application of metagenomic next-generation sequencing in the diagnosis and treatment guidance of Pneumocystis jirovecii pneumonia in renal transplant recipients
نویسندگان
چکیده
Pneumocystis jirovecii pneumonia (PJP) is difficult to be diagnosed, so this study explored if PJP could diagnosed by metagenomic next-generation sequencing (mNGS) and mNGS guide the therapy of PJP. was successfully 13 out 14 recipients with 11 through peripheral blood samples, verified PCR. Ten non-PJP were enrolled as control group. Blood tests revealed a high β-D-glucan (BDG) level in all during hospitalization. Four (28.6%) patients infected cytomegalovirus simultaneously, while 8 (57.1%) suffered from combined infection caused Torque teno virus. Five (35.7%) cases died or subsequent bacteremias/bacterial longer interval between onset diagnosis of/the available against than survival cases. Univariate analysis characteristics that BDG assays higher at admission group (P =0.011). This present supports value detection sample diagnosing PJP, which assist clinical decision for PJ improve outcome The also highlights sensitivity assays. Cytomegalovirus virus infections often occur same time thus can alerts
منابع مشابه
Hypercalcaemia preceding diagnosis of Pneumocystis jirovecii pneumonia in renal transplant recipients
Background The overall incidence of Pneumocystis jirovecii pneumonia (PJP) in solid organ transplant recipients is 5-15%. A timely diagnosis of PJP is difficult and relies on imaging and detection of the organism. Methods We present a case series of four patients displaying hypercalcaemia with an eventual diagnosis of PJP and document the management of the outbreak with a multidisciplinary te...
متن کاملPneumocystis jirovecii genotypes involved in pneumocystis pneumonia outbreaks among renal transplant recipients.
TO THE EDITOR—We read with interest the article by Sassi et al published in Clinical Infectious Diseases [1]. They investigated Pneumocystis jirovecii genotypes involved in Pneumocystis pneumonia (PCP) outbreaks among renal transplant recipients. To that aim, they used fragment length polymorphisms of the major surface glycoprotein gene family. This work revealed that the same P. jirovecii geno...
متن کاملPneumocystis jirovecii pneumonia is rare in renal transplant recipients receiving only one month of prophylaxis.
Prophylaxis against Pneumocystis jirovecii pneumonia (PCP) is recommended for at least 4-12 months after solid organ transplant. In our center, renal transplant recipients receive only 1 month of post-transplant trimethoprim-sulfamethoxazole, which also may provide limited protection against Nocardia. We identified only 4 PCP cases and 4 Nocardia cases in 1352 patients receiving renal and renal...
متن کاملIncreasing frequency of Pneumocystis jirovecii pneumonia in renal transplant recipients in the United Kingdom: clonal variability, clusters, and geographic location.
To the Editor—Pneumocystis jirovecii is a well-described opportunistic pathogen in human immunodeficiency virus (HIV) infection, but it is less commonly associated with pneumonia in other states of immunocompromise. However, outbreaks of P. jirovecii pneumonia (PCP) have been described in renal transplant recipients in both Europe and Asia [1–3]. Explanations for this, including the possible mo...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: European Journal of Clinical Microbiology & Infectious Diseases
سال: 2021
ISSN: ['1435-4373', '0934-9723']
DOI: https://doi.org/10.1007/s10096-021-04254-x